Vivimed Labs acquires stake in Octtantis Nobel LabsIllustrative image – not actual.

Vivimed Labs has acquired stake in Octtantis Nobel Labs (ONL) for an undisclosed sum.


The company has acquired 60 per cent stake in ONL which is currently engaged in trading, manufacturing and marketing of pharmaceutical and nutraceutical formulations conforming to the GMP Standards of World Health Organization. With this acquisition, Vivimed Labs makes foray into the domestic pharma retail and it will synergise this initiative with its extensive experience in manufacturing of formulations at its three existing pharma units.


This apart, Vivimed’s expansion plans include ramping up existing sites at Bidar (Karnataka) and Bonthapally (Andhra Pradesh), besides its greenfield projects located at Choutuppal (Andhra Pradesh) and the SEZ in Srikakulam (Andhra Pradesh). The total investment envisaged for the projects is estiamted at about $42 million (approx Rs 199.5 crore).

← All latest storiesBack to top →